These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6149278)

  • 21. Particle slippage and rearrangement during compression of pharmaceutical powders.
    York P
    J Pharm Pharmacol; 1978 Jan; 30(1):6-10. PubMed ID: 22731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of material attributes and process parameters on the powder bed uniformity during a low-dose dosator capsule filling process.
    Stranzinger S; Faulhammer E; Calzolari V; Biserni S; Dreu R; Šibanc R; Paudel A; Khinast JG
    Int J Pharm; 2017 Jan; 516(1-2):9-20. PubMed ID: 27826028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limitations of the Heckel relation for predicting powder compaction mechanisms.
    Rue PJ; Rees JE
    J Pharm Pharmacol; 1978 Oct; 30(10):642-3. PubMed ID: 30819
    [No Abstract]   [Full Text] [Related]  

  • 25. Low powder mass filling of dry powder inhalation formulations.
    Eskandar F; Lejeune M; Edge S
    Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    Le VN; Bierend H; Robins E; Steckel H; Flament MP
    Int J Pharm; 2012 Jan; 422(1-2):75-82. PubMed ID: 22036653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel standard sample powder preparation method for quantitative analysis of polymorphs.
    Okumura T; Otsuka M
    J Pharm Sci; 2005 May; 94(5):1013-23. PubMed ID: 15793799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of mixing method on the mixing degree during the preparation of triturations.
    Nakamura H; Yanagihara Y; Sekiguchi H; Komada F; Kawabata H; Ohtani M; Saitoh Y; Kariya S; Suzuki H; Uchino K; Iga T
    Yakugaku Zasshi; 2004 Mar; 124(3):127-34. PubMed ID: 15049130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of milling on the plastic and the elastic stiffness of lactose particles.
    Pazesh S; Persson AS; Berggren J; Alderborn G
    Eur J Pharm Sci; 2018 Mar; 114():138-145. PubMed ID: 29217203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of particle shape on the mixing of powders.
    Wong LW; Pilpel N
    J Pharm Pharmacol; 1990 Jan; 42(1):1-6. PubMed ID: 1969942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Powder mixing in direct compression formulation by ordered and random processes.
    Johnson MC
    J Pharm Pharmacol; 1979 May; 31(5):273-6. PubMed ID: 37294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.
    Hertel M; Schwarz E; Kobler M; Hauptstein S; Steckel H; Scherließ R
    Int J Pharm; 2018 Jan; 535(1-2):59-67. PubMed ID: 29100914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anomalies in some properties of powder mixtures.
    Varthalis S; Pilpel N
    J Pharm Pharmacol; 1976 May; 28(5):415-9. PubMed ID: 6749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
    Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
    Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of granule packing and flow behavior based on particle size and shape analysis.
    Sandler N; Wilson D
    J Pharm Sci; 2010 Feb; 99(2):958-68. PubMed ID: 19653280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H; Dahmash E; Bowen J; Mohammed AR
    PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The granulation of ternary mixtures: the effect of the wettability of the powders.
    Jaiyeoba KT; Spring MS
    J Pharm Pharmacol; 1980 Jun; 32(6):386-8. PubMed ID: 6106668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: effect of saturation degree.
    Kaialy W; Nokhodchi A
    Int J Pharm; 2012 Nov; 437(1-2):57-69. PubMed ID: 22884837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.